SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the community discusses the potential impact of a failed Alzheimer's drug trial on its stock, despite its dominance in the obesity market with drugs like Wegovy, where community members speculate on the possibility of a price war. Some investors view the dip as a buying opportunity, emphasizing the company's strong fundamentals and long-term potential in the weight loss sector, while others worry about competition from other pharmaceutical companies. There is also discussion around potential acquisitions and partnerships.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending due to reports of a potential extension of Obamacare subsidies, sparking both bullish and bearish sentiments within the community. Bulls anticipate significant gains if the subsidies are extended, while bears express concerns about the company's long-term viability and potential challenges in improving medical loss ratios. Community members are actively discussing potential price targets, entry points, and the overall impact of policy changes on the healthcare sector.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending amid discussions around its potential involvement in the Jeffrey Epstein case and differing opinions on Jamie Dimon's stance on crypto. The community is divided, with some calling for boycotts and others defending the bank's position; also, there is discussion surrounding JPM's recent moves in the crypto space, with some interpreting these moves as hypocritical.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending as community members discuss the potential impact of its new Gemini 3 model, with some suggesting it could be a game-changer in the AI race and drive further gains. Bullish sentiment is fueled by positive analyst ratings and Waymo's expansion, while some traders are closely watching for a potential pullback after the recent surge.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide ($WRD) is trending due to robotaxi revenue growth and global expansion milestones, including approvals for driverless operations in Abu Dhabi and partnerships with Uber and Grab. The community is buzzing about the company's potential to monetize AI and compete with Tesla in the robotaxi market. Discussions also highlight WeRide's strategic partnerships and the rapid development of China's autonomous driving technology.

Monad

Monad is trending as its public mainnet launch and token listing approaches, sparking excitement and debate within the crypto community. Discussions revolve around the token distribution process, potential for profit, and where to purchase, alongside speculation about a possible initial price surge and subsequent dip. Some users express concerns about it being a potential scam, while others highlight its listing on Coinbase as a positive sign.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as its Qwen AI app reached 10 million downloads, driving optimism despite broader market AI skepticism. Community members are actively discussing the app's potential to rival ChatGPT and the implications for Alibaba's AI strategy. The news has sparked debate about the stock's valuation and future prospects within the competitive tech landscape.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

MOH is trending as the community discusses its recent rating adjustments from various firms and a significant price drop following disappointing earnings, which missed estimates due to rising medical costs. Community members are weighing the potential for a rebound, citing the company's balance sheet, while others express concerns about sector-wide challenges and potential downgrades. Discussions also revolve around the impact of Medicaid and Medicare policies on the company's revenue streams.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Biogen Inc

Biogen ($BIIB) is trending due to Novo Nordisk's Alzheimer's drug trial failure, boosting interest in BIIB's CNS pipeline. The community is discussing Biogen's potential upside in the Alzheimer's space and recent analyst upgrades. Biogen's strategic focus on CNS and Alzheimer's treatments is being highlighted amid renewed interest in the sector.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

MSI is trending due to community focus on technical analysis, particularly positive divergence and significant dark pool activity suggesting a potential oversold bounce. Traders are pointing to a large dark pool print as a sign of a bottom and reversal. The stock's oversold condition and potential for a bounce are key talking points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CarMax (KMX.N) is well-positioned to capture greater market share in the used car sector, supported by its omnichannel platform, a stable pricing environment, and rising demand for late-model used vehicles, according to Wedbush.According to a report in MT&nbsp;Newswires, the brokerage said CarMax remains confident in its growth prospects, even after withdrawing its long-term targets due to macroeconomic uncertainty.Wedbush noted that used car store sales picked up in March and April, driven by consumer concerns over the potential rise in prices of new vehicles from tariffs.It added that CarMax’s focus on newer used models and operational efficiency makes it well-suited to benefit from the shift.Earlier this month, CarMax&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/carmax-shares-dive-on-weak-q4-print/chfrOOqRb93">reported</a> fourth-quarter profit and car sales that missed analyst estimates.The company also removed the timeline for some of its long-term targets, such as selling more than 2 million retail and wholesale units annually between fiscal 2026 and 2030.Wedbush said while tariffs could raise parts costs, the overall impact on reconditioning expenses is limited, and CarMax is largely shielded from supply disruptions as it sources most inventory independently.Wedbush maintained its ‘Outperform’ rating on CarMax, with a price target of $90, implying an over 44% upside from the last closing price.On Stocktwits, the retail sentiment jumped to 'Neutral' from 'Bearish' a day ago.<figure class="image"><img style="aspect-ratio:815/188;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_22_at_8_29_08_AM_png_1e5be06519.webp" alt="Screenshot 2025-04-22 at 8.29.08 AM.png" width="815" height="188"><figcaption>KMX sentiment and message volume as of April 21 | Source: Stocktwits</figcaption></figure>Users noted that as tariffs drive up prices, more consumers are expected to turn to used cars—making it a logical time to load up on CarMax shares.<stembedurl>https://stocktwits.com/1of402Phase2TrialUSA/message/611933545</stembedurl><stembedurl>https://stocktwits.com/Stockninja1980/message/611816401</stembedurl>CarMax&nbsp;<a href="https://stocktwits.com/symbol/KMX">stock</a> is down 23.8% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A view of a CarMax dealership on April 10, 2025 in Santa Rosa, California. (Photo by Justin Sullivan/Getty Images)

CarMax Well Positioned For Growth, Says Wedbush: Retail Sentiment Improves

Wedbush said while tariffs could raise parts costs, the overall impact on reconditioning expenses is limited, and CarMax is largely shielded from supply disruptions as it sources most inventory independently.

Equity

Wedbush said while tariffs could raise parts costs, the overall impact on reconditioning expenses is limited, and CarMax is largely shielded from supply disruptions as it sources most inventory independently.


CarMax Inc (KMX) shares fell 17% on Thursday after the used car retailer's fourth-quarter results largely missed expectations.Adjusted profit was $0.64 per share for the quarter ended Feb. 28, below estimated $0.65 per share, according to Reuters/LSEG.Revenue grew 6.7% to $6 billion, narrowly beating estimates of $5.9 billion. However, the number of cars sold, 301,811, was below analysts' expectations of 312,800.CarMax is the largest used car retailer in the United States, operating online and through its over 250 centers nationwide.Shares, which saw their worst decline since September 2022, were also weighed by the company's decision to remove timelines associated with certain long-term goals, "given the potential impact of broader macro factors."President Donald Trump has raised tariffs on imports from all major countries.&nbsp;Although some of the&nbsp;levies have been paused and will likely be renegotiated, companies across industries are bracing for higher prices and disruptions in their supply chains.On Stocktwits, retail sentiment held in the 'bullish' territory, and message volume jumped to 'extremely high' from a day earlier.<figure class="image"><img style="aspect-ratio:806/189;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_11_at_12_24_26_PM_png_0c885a722e.webp" alt="Screenshot 2025-04-11 at 12.24.26 PM.png" width="806" height="189"><figcaption>KMX sentiment and message volume as of April 10 | Source: Stocktwits</figcaption></figure>One user said that as automobile prices are expected to rise, a large portion of buyers might turn to used cars, thus benefiting CarMax.<stembedurl>https://stocktwits.com/powellpnd/message/611238153</stembedurl>Another user said the stock could go above $75&nbsp;if&nbsp;major U.S. banks report strong results on Friday.<stembedurl>https://stocktwits.com/profit_guru/message/611267923</stembedurl>KMX shares closed at $66.45 on Thursday. They are down 18.7% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

CarMax Shares Dive On Weak Q4 Print, But Retail Bets Trump Tariffs Will Rev Up Used Car Demand  

Stock fell 17%, its worst single-day decline since September 2022.

Shares of Helen of Troy Ltd. (HELE) were up nearly 1% on Wednesday after the maker of branded beauty, wellness, and household products reported upbeat second-quarter earnings, even as it drew a lukewarm reaction from retail.Consolidated net sales revenue fell 3.5% to $474.2 million, reflecting a decline in the sale of hair appliances, air purifiers, and humidifiers, but beat analyst estimates of $458.85 million.Net income fell to $17 million from $27.4 million a year earlier. However, adjusted earnings per share came in at $1.21, beating expectations of $1.05.“Despite persistent macro headwinds, we achieved early results on our efforts to 'Reset and Revitalize' our business, driven by improved brand fundamentals, optimized marketing and innovation, and expanded distribution,” said CEO Noel Geoffroy.<figure class="image"><a href="https://stocktwits.com/symbol/HELE"><img style="aspect-ratio:1302/366;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_09_at_5_44_24_PM_5dd42a3512.png" alt="Screenshot Caption: HELE stock’s sentiment meter as of 8:14 am ET on Oct. 09, 2024. | Source: Stocktwits" width="1302" height="366"></a><figcaption>Screenshot Caption: HELE stock’s sentiment meter as of &nbsp;8:14 am ET on Oct. 09, 2024. | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment for HELE following the results edged up into ‘neutral’ (50/100) territory from ‘bearish’ a day ago.<stembedurl>https://stocktwits.com/bananex/message/588419541</stembedurl>The maker of household and beauty products such as Vicks, Braun, and Revlon also reaffirmed its full-year outlook for net sales, adjusted EPS, and adjusted EBITDA.&nbsp;It expects its fiscal 2025 sales to fall between $1.885 billion and $1.935 billion, a decline of 6.0% to 3.5% that it attributes to continuing inflation and softness in consumer spending. &nbsp;It expects adjusted EPS to be between $7 and $7.50, and adjusted Ebitda between $287 million and $297 million.&nbsp;HELE’s stock is down 49% year-to-date.&nbsp;

Helen Of Troy Stock Inches Up After Q2 Earnings Beat Estimates, Retail Sentiment Remains Lukewarm

The maker of household and beauty products such as Vicks, Braun, and Revlon also reaffirmed its full-year outlook for net sales, adjusted EPS, and adjusted EBITDA

Helen Of Troy Stock Inches Up After Q2 Earnings Beat, Retail Sentiment Remains Lukewarm

The maker of household and beauty products such as Vicks, Braun, and Revlon also reaffirmed its full-year outlook for net sales, adjusted EPS, and adjusted EBITDA



VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the Ontario Superior...

U.S. stocks closed mixed Tuesday, with the Dow Jones rising ahead of key earnings and Fed decisions. Before the opening bell on Wednesday, Faraday Future, Nvidia, and VBI Vaccines are drawing significant market attention from the list of most actively traded stocks.Faraday Future Intelligent Electric Inc. (FFIE): Faraday Future stock surged over 21% to $0.38 pre-market after regaining Nasdaq compliance. The EV-maker reported a reduced operating loss of $43.60 million in Q1 from $95.80 million a year ago, and operating expenses fell from $95.80 million to $22.90 million.&nbsp;Last week's Investor Community Day also boosted sentiment. Short interest has dropped to 7.76% from the start of the year. Stocktwits sentiment improved from bearish to neutral (48/100).<figure class="image"><a href="https://stocktwits.com/symbol/FFIE"><img style="aspect-ratio:1308/310;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/FFIE_premakret_sentiment_and_message_score_Jul_31_35799e547d.png" alt="FFIE premakret sentiment and message score Jul 31.png" width="1308" height="310"></a><figcaption>FFIE premarket sentiment and message score Jul 31</figcaption></figure>Nvidia Corp. (NVDA): Nvidia shares are up alongside other chip stocks premarket, likely due to AMD's strong Q2 and whispers of potential new export rules benefiting chipmakers. The Biden administration is reportedly contemplating tweaking a rule on foreign chip equipment exports, which could exempt Japan, the Netherlands, and South Korea.Stocktwits data showed that NVDA’s retail following turned more cheerful on this development, as the sentiment score flipped from neutral a day earlier to extremely bullish (85/100) amid high message volumes. Nvidia is due to report Q2 results on Aug. 28 after market close.<figure class="image"><a href="https://stocktwits.com/symbol/NVDA"><img style="aspect-ratio:1314/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/NVDA_premakret_sentiment_and_message_score_Jul_31_40f1f1a154.png" alt="NVDA premakret sentiment and message score Jul 31.png" width="1314" height="308"></a><figcaption>NVDA premarket sentiment and message score Jul 31</figcaption></figure> VBI Vaccines Inc. (VBIV): VBI Vaccines rose nearly 3% pre-market after crashing over 77% in the previous session following the biopharma company's bankruptcy plan and asset sale announcements. It is seeking creditor protection in Canada and expecting to be delisted from the Nasdaq.The firm also intends to file for Chapter 15 bankruptcy in the U.S. Stocktwits sentiment reflected investors’ gloom as retail sentiment hit extremely bearish levels (4/100), the lowest this year. At the same time, message volumes reached a 2024 peak at 'extremely high' (97/100) levels.<figure class="image"><a href="https://stocktwits.com/symbol/VBIV"><img style="aspect-ratio:1312/304;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/VBIV_premakret_sentiment_and_message_score_Jul_31_f4d2586afe.png" alt="VBIV premakret sentiment and message score Jul 31.png" width="1312" height="304"></a><figcaption>VBIV premarket sentiment and message score Jul 31</figcaption></figure>

Pre-Market Movers: Retail's Pulse On Faraday Future, Nvidia and VBI Vaccines

EV-maker Faraday Future had some pleasing news for investors, as shares rocketed before the bell. Nvidia, meanwhile, rode on the cheer surrounding a rival’s strong earnings. But for VBI Vaccines, it has come down to a fight for survival.

Wednesday Pre-Market Movers: What’s Retail Pulse On Faraday Future, Nvidia and VBI Vaccines?

EV-maker Faraday Future had some pleasing news for investors, as shares rocketed before the bell. Nvidia, meanwhile, rode on the cheer surrounding a rival’s strong earnings. But for VBI Vaccines, it has come down to a fight for survival.


VBI Vaccines Announces Results of Annual General Meeting

VBI Vaccines Inc. (Nasdaq: VBIV) ('VBI' or the 'Company'), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the voting...

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced new interim tumor response...

VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor...

VBI Vaccines Reports First Quarter 2024 Financial Results

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced...

VBI Vaccines Reports Full Year 2023 Financial Results

VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '24	-$0.32	--	--	N/A
Q1 '24	-$0.53	-$0.55	-3.77%	MISSED
Q4 '23	-$0.22	$1.02	563.64%	BEAT
Q3 '23	-$0.14	-$0.38	-171.43%	MISSED
Q2 '23	-$2.16	-$2.17	-0.46%	MISSED

VBIV
VBI Vaccines Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '24

Historical Earnings

Latest VBIV News

VBIVVBI Vaccines Inc.